Cost-effectiveness of human papillomavirus vaccination and cervical cancer screening in Thailand

Preventing Cervical Cancer

(2010) Lee A. Trope et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus‐Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Generally HPV‐Naive Women Aged 16–26 Years

(2009) Darron R. Brown et al.   JOURNAL OF INFECTIOUS DISEASES

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

(2009) J Paavonen et al.   LANCET

HPV Screening for Cervical Cancer in Rural India

(2009) Rengaswamy Sankaranarayanan et al.   NEW ENGLAND JOURNAL OF MEDICINE

New paradigms in cervical cancer prevention: opportunities and risks

(2009) Guglielmo Ronco et al.   BMC Womens Health

Health and economic impact of HPV 16 and 18 vaccination and cervical cancer screening in India

(2008) M Diaz et al.   BRITISH JOURNAL OF CANCER

Exploring the cost-effectiveness of HPV vaccination in Vietnam: Insights for evidence-based cervical cancer prevention policy

(2008) Jane J. Kim et al.   VACCINE

Epidemiology and Prevention of Cervical Cancer in Indonesia, Malaysia, the Philippines, Thailand and Vietnam

(2008) Efren J. Domingo et al.   VACCINE